Literature DB >> 9795025

Rheological evaluation of poloxamer as an in situ gel for ophthalmic use.

K Edsman1, J Carlfors, R Petersson.   

Abstract

The contact time of a vehicle on the cornea is of utmost importance for ocular drug delivery. In the present study rheological measurements were performed to study the gel and the sol-gel transition of an in situ gel, Poloxamer 407. The rheological measurements and a small in vivo study of ocular residence times in humans were used to evaluate poloxamer as an ocular vehicle. An increasing concentration of poloxamer resulted in a slightly increasing elasticity of the gels and a decreasing sol-gel transition temperature. The contact time increased with increasing concentration of poloxamer which could be explained and correlated with the rheology of poloxamer solutions/gels mixed with simulated tear fluid. The maximum contact time for the preparations studied was about 1 h. The poloxamer system did not seem to be promising as an ophthalmic in situ gel due to the strong concentration dependence of the sol-gel transition temperature combined with the dilution that occurs in the eye.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795025     DOI: 10.1016/s0928-0987(97)00075-4

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  29 in total

Review 1.  A review of poloxamer 407 pharmaceutical and pharmacological characteristics.

Authors:  Gilles Dumortier; Jean Louis Grossiord; Florence Agnely; Jean Claude Chaumeil
Journal:  Pharm Res       Date:  2006-11-11       Impact factor: 4.200

2.  Microneedle-mediated intrascleral delivery of in situ forming thermoresponsive implants for sustained ocular drug delivery.

Authors:  Raghu Raj Singh Thakur; Steven J Fallows; Hannah L McMillan; Ryan F Donnelly; David S Jones
Journal:  J Pharm Pharmacol       Date:  2013-10-16       Impact factor: 3.765

3.  A methylcellulose and collagen based temperature responsive hydrogel promotes encapsulated stem cell viability and proliferation in vitro.

Authors:  Christina Payne; Eimear B Dolan; Janice O'Sullivan; Sally-Ann Cryan; Helena M Kelly
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

4.  Effects of Topical Atorvastatin (2 %) on Posthemorrhoidectomy Pain and Wound Healing: A Randomized Double-Blind Placebo-Controlled Clinical Trial.

Authors:  Shahram Ala; Mina Alvandipour; Majid Saeedi; Maliheh Hamidian; Afshin Shiva; Nasrin Rahmani; Fatemeh Faramarzi
Journal:  World J Surg       Date:  2017-02       Impact factor: 3.352

5.  Thermoreversible nasal in situ gel of venlafaxine hydrochloride: formulation, characterization, and pharmacodynamic evaluation.

Authors:  Mandar J Bhandwalkar; Amelia M Avachat
Journal:  AAPS PharmSciTech       Date:  2012-12-11       Impact factor: 3.246

Review 6.  Advances and limitations of drug delivery systems formulated as eye drops.

Authors:  Clotilde Jumelle; Shima Gholizadeh; Nasim Annabi; Reza Dana
Journal:  J Control Release       Date:  2020-02-03       Impact factor: 9.776

7.  A novel transdermal delivery system for the anti-inflammatory lumiracoxib: influence of oleic acid on in vitro percutaneous absorption and in vivo potential cutaneous irritation.

Authors:  Tailane Sant'Anna Moreira; Valéria Pereira de Sousa; Maria Bernadete Riemma Pierre
Journal:  AAPS PharmSciTech       Date:  2010-04-07       Impact factor: 3.246

8.  Tailored Doxycycline Hyclate Loaded In Situ Gel for the Treatment of Periodontitis: Optimization, In Vitro Characterization, and Antimicrobial Studies.

Authors:  Ketan M Ranch; Furqan A Maulvi; Akshay R Koli; Ditixa T Desai; Rajesh K Parikh; Dinesh O Shah
Journal:  AAPS PharmSciTech       Date:  2021-02-17       Impact factor: 3.246

Review 9.  Achievements in Thermosensitive Gelling Systems for Rectal Administration.

Authors:  Maria Bialik; Marzena Kuras; Marcin Sobczak; Ewa Oledzka
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

10.  Nanoparticles laden in situ gelling system for ocular drug targeting.

Authors:  Divya Kumar; Nidhi Jain; Neha Gulati; Upendra Nagaich
Journal:  J Adv Pharm Technol Res       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.